HEADER SUGAR BINDING PROTEIN 18-OCT-21 7SJL TITLE SOLUTION NMR STRUCTURE OF IMMUNOGLOBULIN-LIKE DOMAIN OF HUMAN TITLE 2 NEUREGULIN-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUREGULIN-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACETYLCHOLINE RECEPTOR-INDUCING ACTIVITY,ARIA,BREAST CANCER COMPND 5 CELL DIFFERENTIATION FACTOR P45,GLIAL GROWTH FACTOR,HEREGULIN,HRG,NEU COMPND 6 DIFFERENTIATION FACTOR,SENSORY AND MOTOR NEURON-DERIVED FACTOR; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NRG1, GGF, HGL, HRGA, NDF, SMDF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-21B(+) KEYWDS HEPARAN-SULFATE BINDING, SUGAR BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.ELETSKY,Y.KIM,M.J.ROGALS,J.H.PRESTEGARD REVDAT 2 14-JUN-23 7SJL 1 REMARK REVDAT 1 18-MAY-22 7SJL 0 JRNL AUTH N.A.KHAJE,A.ELETSKY,S.E.BIEHN,C.K.MOBLEY,M.J.ROGALS,Y.KIM, JRNL AUTH 2 S.K.MISHRA,R.J.DOERKSEN,S.LINDERT,J.H.PRESTEGARD,J.S.SHARP JRNL TITL VALIDATED DETERMINATION OF NRG1 IG-LIKE DOMAIN STRUCTURE BY JRNL TITL 2 MASS SPECTROMETRY COUPLED WITH COMPUTATIONAL MODELING JRNL REF COMMUN BIOL V. 5 452 2022 JRNL REFN ESSN 2399-3642 JRNL DOI 10.1038/S42003-022-03411-Y REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINED IN EXPLICT WATER BATH USING REMARK 3 PARAM19 FORCE FIELD REMARK 4 REMARK 4 7SJL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260312. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298 REMARK 210 PH : 6.5; 7.5 REMARK 210 IONIC STRENGTH : 100; 300 REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 2.0 MM [U-13C; U-15N] NRG1-IG, REMARK 210 20 MM SODIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 4 UM DSS, 0.05 % REMARK 210 W/W SODIUM AZIDE, 93% H2O/7% REMARK 210 D2O; 0.45 MM [U-13C; U-15N] NRG1- REMARK 210 IG, 20 MM SODIUM PHOSPHATE, 100 REMARK 210 MM SODIUM CHLORIDE, 4 UM DSS, REMARK 210 0.05 % W/W SODIUM AZIDE, 93% H2O/ REMARK 210 7% D2O; 0.34 MM [5% 13C; U-15N] REMARK 210 NRG1-IG, 20 MM TRIS, 300 MM REMARK 210 SODIUM CHLORIDE, 5 UM DSS, 0.05 % REMARK 210 W/W SODIUM AZIDE, 93% H2O/7% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C CT REMARK 210 -HSQC ALIPHATIC; 2D 1H-13C CT- REMARK 210 HSQC AROMATIC; 3D (HACA)CONH; 3D REMARK 210 HNCACB; 3D HBHA(CO)NH; 3D (H)CCH- REMARK 210 COSY AROMATIC; 3D (H)CCH-COSY REMARK 210 ALIPHATIC; 3D (H)CCH-TOCSY REMARK 210 ALIPHATIC; 3D 1H-13C,15N NOESY; REMARK 210 3D HNCO; 3D CBCA(CO)NH; 2D 1H- REMARK 210 13C CT-HSQC METHYL REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.98.13, ASDP 1.0, CARA REMARK 210 1.9.1.7, AUTOASSIGN 2.3.0, REMARK 210 TOPSPIN 4.0, NMRPIPE, TALOS-N, REMARK 210 PSVS 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 2 99.38 -63.80 REMARK 500 1 HIS A 5 -162.35 59.60 REMARK 500 1 HIS A 6 87.99 61.73 REMARK 500 1 ARG A 11 -41.50 -159.09 REMARK 500 1 LEU A 14 -29.79 -152.15 REMARK 500 1 PRO A 77 93.60 -64.97 REMARK 500 1 SER A 117 97.26 -67.07 REMARK 500 2 HIS A 2 -5.92 70.41 REMARK 500 2 HIS A 4 -79.88 -129.23 REMARK 500 2 SER A 8 95.37 -69.43 REMARK 500 2 GLU A 26 109.55 -47.83 REMARK 500 2 LYS A 86 72.96 52.18 REMARK 500 3 HIS A 7 93.29 -62.50 REMARK 500 3 GLN A 17 92.11 56.68 REMARK 500 3 TYR A 48 -80.19 59.93 REMARK 500 3 SER A 49 -70.91 -173.08 REMARK 500 3 PRO A 77 86.62 -66.11 REMARK 500 3 SER A 80 139.92 -171.69 REMARK 500 3 LYS A 86 72.53 59.85 REMARK 500 3 SER A 117 98.40 -62.33 REMARK 500 4 HIS A 2 -61.62 -143.46 REMARK 500 4 HIS A 3 132.21 69.41 REMARK 500 4 SER A 9 90.10 -68.95 REMARK 500 4 PHE A 16 75.62 63.01 REMARK 500 4 SER A 50 92.58 67.15 REMARK 500 4 PRO A 77 99.91 -50.91 REMARK 500 4 SER A 117 92.27 -67.15 REMARK 500 5 SER A 9 -64.34 -100.26 REMARK 500 5 TYR A 48 -165.23 57.53 REMARK 500 5 GLU A 61 109.67 -57.56 REMARK 500 5 LEU A 62 93.28 -68.48 REMARK 500 5 PRO A 77 94.42 -50.77 REMARK 500 5 LYS A 86 70.31 55.45 REMARK 500 6 HIS A 4 92.51 -65.06 REMARK 500 6 HIS A 7 91.69 -67.89 REMARK 500 6 ASN A 13 51.89 -108.01 REMARK 500 6 PRO A 77 94.81 -62.02 REMARK 500 6 SER A 117 109.92 -59.37 REMARK 500 7 ARG A 11 56.91 -142.08 REMARK 500 7 LEU A 14 -159.32 -111.73 REMARK 500 7 PRO A 22 91.89 -67.01 REMARK 500 7 SER A 50 85.95 62.62 REMARK 500 7 LEU A 62 92.73 -69.29 REMARK 500 7 PRO A 77 97.44 -62.36 REMARK 500 8 HIS A 5 -161.13 59.22 REMARK 500 8 HIS A 6 -173.43 65.89 REMARK 500 8 SER A 9 -169.11 64.18 REMARK 500 8 GLN A 17 -85.40 61.18 REMARK 500 8 SER A 50 45.18 -93.76 REMARK 500 8 PRO A 77 96.84 -51.93 REMARK 500 REMARK 500 THIS ENTRY HAS 114 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30960 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF IMMUNOGLOBULIN-LIKE DOMAIN OF HUMAN REMARK 900 NEUREGULIN-1 DBREF 7SJL A 19 118 UNP Q02297 NRG1_HUMAN 34 133 SEQADV 7SJL MET A 1 UNP Q02297 INITIATING METHIONINE SEQADV 7SJL HIS A 2 UNP Q02297 EXPRESSION TAG SEQADV 7SJL HIS A 3 UNP Q02297 EXPRESSION TAG SEQADV 7SJL HIS A 4 UNP Q02297 EXPRESSION TAG SEQADV 7SJL HIS A 5 UNP Q02297 EXPRESSION TAG SEQADV 7SJL HIS A 6 UNP Q02297 EXPRESSION TAG SEQADV 7SJL HIS A 7 UNP Q02297 EXPRESSION TAG SEQADV 7SJL SER A 8 UNP Q02297 EXPRESSION TAG SEQADV 7SJL SER A 9 UNP Q02297 EXPRESSION TAG SEQADV 7SJL GLY A 10 UNP Q02297 EXPRESSION TAG SEQADV 7SJL ARG A 11 UNP Q02297 EXPRESSION TAG SEQADV 7SJL GLU A 12 UNP Q02297 EXPRESSION TAG SEQADV 7SJL ASN A 13 UNP Q02297 EXPRESSION TAG SEQADV 7SJL LEU A 14 UNP Q02297 EXPRESSION TAG SEQADV 7SJL TYR A 15 UNP Q02297 EXPRESSION TAG SEQADV 7SJL PHE A 16 UNP Q02297 EXPRESSION TAG SEQADV 7SJL GLN A 17 UNP Q02297 EXPRESSION TAG SEQADV 7SJL GLY A 18 UNP Q02297 EXPRESSION TAG SEQRES 1 A 118 MET HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU ASN SEQRES 2 A 118 LEU TYR PHE GLN GLY ALA LEU PRO PRO ARG LEU LYS GLU SEQRES 3 A 118 MET LYS SER GLN GLU SER ALA ALA GLY SER LYS LEU VAL SEQRES 4 A 118 LEU ARG CYS GLU THR SER SER GLU TYR SER SER LEU ARG SEQRES 5 A 118 PHE LYS TRP PHE LYS ASN GLY ASN GLU LEU ASN ARG LYS SEQRES 6 A 118 ASN LYS PRO GLN ASN ILE LYS ILE GLN LYS LYS PRO GLY SEQRES 7 A 118 LYS SER GLU LEU ARG ILE ASN LYS ALA SER LEU ALA ASP SEQRES 8 A 118 SER GLY GLU TYR MET CYS LYS VAL ILE SER LYS LEU GLY SEQRES 9 A 118 ASN ASP SER ALA SER ALA ASN ILE THR ILE VAL GLU SER SEQRES 10 A 118 ASN HELIX 1 AA1 SER A 88 SER A 92 5 5 SHEET 1 AA1 5 GLN A 30 ALA A 33 0 SHEET 2 AA1 5 ASN A 105 VAL A 115 1 O THR A 113 N GLN A 30 SHEET 3 AA1 5 GLY A 93 ILE A 100 -1 N CYS A 97 O ALA A 108 SHEET 4 AA1 5 ARG A 52 LYS A 57 -1 N PHE A 56 O MET A 96 SHEET 5 AA1 5 ASN A 60 GLU A 61 -1 O ASN A 60 N LYS A 57 SHEET 1 AA2 3 SER A 36 GLU A 43 0 SHEET 2 AA2 3 LYS A 79 ALA A 87 -1 O ILE A 84 N LEU A 38 SHEET 3 AA2 3 ILE A 71 LYS A 76 -1 N GLN A 74 O GLU A 81 SSBOND 1 CYS A 42 CYS A 97 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1